| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |